BASF to Develop a High Purity Poloxamer for Mast Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. SEDG
8. QQQ
9. TENB
10. SPCX

Go back to BASF to Develop a High Purity Poloxamer for Mast Therapeutics
MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 15.10 +1.55 (11.44%)
Previous Close $13.55    52 Week High $0.71 
Open $13.97    52 Week Low $0.07 
Day High $15.49    P/E N/A 
Day Low $13.69    EPS $-0.35 
Volume 5,042,909       

MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 15.10 +1.55 (11.44%)
Previous Close $13.55    52 Week High $0.71 
Open $13.97    52 Week Low $0.07 
Day High $15.49    P/E N/A 
Day Low $13.69    EPS $-0.35 
Volume 5,042,909